Cumberland Pharmaceuticals Inc. (CPIX)
CPIX moved a median of 0.00% 30 minutes after news, and +0.41% by the close. How CPIX actually reacts to news — the realized, point-in-time move the market made, measured across 245 labeled events over the last three years with zero look-ahead.
CPIX’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 40% | 205 |
| 30-min | 0.00% | 49% | 226 |
| 60-min | 0.00% | 49% | 236 |
| to close | +0.41% | 50% | 244 |
| Middle 50% of CPIX reactions | -1.16% to +2.59% |
|---|---|
| Median reaction (30-min) | 0.00% |
| Measured reactions | 245 |
Half of all Cumberland Pharmaceuticals Inc. news events land between -1.16% and +2.59% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when CPIX moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to CPIX's baseline. Nothing else.
Recent CPIX events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Form 8-K/A CUMBERLAND PHARMACEUTICA For: Apr 21 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +5.02% | |
| Form 8-K CUMBERLAND PHARMACEUTICA For: Aug 28 | SEC filing · Form 8-K | SEC EDGAR | +1.46% | -18.51% | |
| Form 10-Q CUMBERLAND PHARMACEUTICA For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | -0.26% | — | |
| CUMBERLAND PHARMACEUTICALS REPORTS COMPANY UPDATE & Q2 2026 FINANCIAL RESULTS | Press release | PR Newswire | +3.08% | +3.28% | |
| Form 8-K CUMBERLAND PHARMACEUTICA For: Aug 04 | SEC filing · Form 8-K | SEC EDGAR | +3.08% | +3.28% | |
| CUMBERLAND PHARMACEUTICALS TO ANNOUNCE COMPANY UPDATE & Q2 2026 FINANCIAL RESULTS | Press release | PR Newswire | — | -2.20% | |
| CUMBERLAND PHARMACEUTICALS ANNOUNCES SPECIAL DIVIDEND OF $1.50 PER SHARE | Press release | PR Newswire | +1.09% | +8.46% | |
| Form 8-K CUMBERLAND PHARMACEUTICA For: Jul 13 | SEC filing · Form 8-K | SEC EDGAR | -1.51% | +5.83% | |
| Cumberland Pharmaceuticals Closes Strategic Transaction with Apotex | Press release | PR Newswire | -0.84% | +8.52% | |
| Form 8-K CUMBERLAND PHARMACEUTICA For: Jun 29 | SEC filing · Form 8-K | SEC EDGAR | +0.84% | -10.91% | |
| Cumberland Pharmaceuticals Shares Updated FIGHT DMD Trial Results at the Parent Project Muscular Dystrophy Annual Conference | Press release | PR Newswire | +4.16% | +12.31% | |
| Form 8-K CUMBERLAND PHARMACEUTICA For: Jun 24 | SEC filing · Form 8-K | SEC EDGAR | +2.27% | +13.26% | |
| Cumberland Pharmaceuticals and Vanderbilt Health Announce Potential New Therapy to Prevent Cancer Metastasis | Press release | PR Newswire | +0.00% | +3.40% | |
| CUMBERLAND PHARMACEUTICALS ANNOUNCES LAUNCH OF VIBATIV® IN CHINA | Press release | PR Newswire | +1.01% | +1.01% | |
| Form DEFM14A CUMBERLAND PHARMACEUTICA | SEC filing · Form DEFM14A | SEC EDGAR | +1.70% | -1.87% | |
| Form PREM14A CUMBERLAND PHARMACEUTICA For: May 15 | SEC filing · Form PREM14A | SEC EDGAR | +0.65% | -4.30% | |
| Form 10-Q CUMBERLAND PHARMACEUTICA For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +0.00% | +0.66% | |
| CUMBERLAND PHARMACEUTICALS REPORTS Q1 2026 FINANCIAL RESULTS & COMPANY UPDATE | Press release | PR Newswire | -2.15% | -3.10% | |
| Form 8-K CUMBERLAND PHARMACEUTICA For: May 05 | SEC filing · Form 8-K | SEC EDGAR | -2.15% | -3.10% | |
| CUMBERLAND PHARMACEUTICALS TO ANNOUNCE Q1 2026 FINANCIAL RESULTS & COMPANY UPDATE | Press release | PR Newswire | -0.76% | +0.96% | |
| Form 8-K CUMBERLAND PHARMACEUTICA For: Apr 21 | SEC filing · Form 8-K | SEC EDGAR | -1.10% | +2.44% | |
| Cumberland Pharmaceuticals Announces Strategic Transaction to Integrate Commercial Business with Apotex | Press release | PR Newswire | -10.41% | -32.29% | |
| Form 8-K CUMBERLAND PHARMACEUTICA For: Apr 22 | SEC filing · Form 8-K | SEC EDGAR | -10.41% | -32.29% | |
| Form DEFA14A CUMBERLAND PHARMACEUTICA | SEC filing · Form DEFA14A | SEC EDGAR | -10.41% | -32.29% | |
| CUMBERLAND PHARMACEUTICALS ANNOUNCES EXPANDED INDICATION FOR CALDOLOR® (IBUPROFEN) INJECTION AND LAUNCH OF NEW BRAND WEBSITE | Press release | PR Newswire | +0.31% | -4.63% | |
| Cumberland Pharmaceuticals Launches New Sancuso® Website Featuring Educational Resources for Chemotherapy-Induced Nausea and Vomiting | Press release | PR Newswire | +2.78% | -1.63% | |
| Form ARS CUMBERLAND PHARMACEUTICA For: Mar 12 | SEC filing · Form ARS | SEC EDGAR | — | -2.25% | |
| Form 10-K CUMBERLAND PHARMACEUTICA For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | +3.26% | -0.87% | |
| Form DEF 14A CUMBERLAND PHARMACEUTICA For: Dec 31 | SEC filing · Form DEF | SEC EDGAR | — | -6.79% | |
| Form DEFA14A CUMBERLAND PHARMACEUTICA | SEC filing · Form DEFA14A | SEC EDGAR | — | -6.79% | |
| CUMBERLAND PHARMACEUTICALS REPORTS 31% FOURTH QUARTER 2025 REVENUE GROWTH | Press release | PR Newswire | -0.66% | -19.87% | |
| Form 8-K CUMBERLAND PHARMACEUTICA For: Mar 03 | SEC filing · Form 8-K | SEC EDGAR | -0.66% | -19.87% | |
| CUMBERLAND PHARMACEUTICALS LAUNCHES U.S. PROMOTION OF TALICIA® | Press release | PR Newswire | +0.75% | +2.50% | |
| CUMBERLAND PHARMACEUTICALS TO ANNOUNCE 2025 ANNUAL FINANCIAL RESULTS & COMPANY UPDATE | Press release | PR Newswire | +0.75% | +2.50% | |
| Cumberland Pharmaceuticals Receives FDA Fast Track Designation for its Ifetroban Duchenne Muscular Dystrophy Program | Press release | PR Newswire | -1.89% | -1.50% | |
| Form 8-K CUMBERLAND PHARMACEUTICA For: Feb 04 | SEC filing · Form 8-K | SEC EDGAR | -2.07% | -7.00% | |
| CALDOLOR® (IBUPROFEN) INJECTION CMS ISSUED J-CODE NOW ASSOCIATED WITH REIMBURSEMENT PRICE SUPPORTING NON-OPIOID PAIN MANAGEMENT | Press release | PR Newswire | +0.00% | -9.96% | |
| Form 8-K CUMBERLAND PHARMACEUTICA For: Nov 18 | SEC filing · Form 8-K | SEC EDGAR | — | +1.80% | |
| Form 10-Q CUMBERLAND PHARMACEUTICA For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.96% | -5.26% | |
| CUMBERLAND PHARMACEUTICALS REPORTS 12% YEAR-TO-DATE REVENUE GROWTH | Press release | PR Newswire | +0.00% | -10.04% | |
| Form 8-K CUMBERLAND PHARMACEUTICA For: Nov 04 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -10.04% | |
| CUMBERLAND PHARMACEUTICALS TO ANNOUNCE Q3 2025 FINANCIAL RESULTS & COMPANY UPDATE | Press release | PR Newswire | — | -1.81% | |
| Form 8-K CUMBERLAND PHARMACEUTICA For: Oct 21 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +0.83% | |
| CUMBERLAND PHAMACEUTICALS ANNOUNCES THE ADDITION OF AN ESTABLISHED FDA APPROVED PRODUCT TO ITS COMMERCIAL PORTFOLIO | Press release | PR Newswire | -0.88% | +4.71% | |
| CUMBERLAND PHARMACEUTICALS' VIBATIV® ADDED TO NATIONAL GROUP PURCHASING AGREEMENT WITH PREMIER, INC. | Press release | PR Newswire | +0.86% | -3.45% | |
| CUMBERLAND PHARMACEUTICALS ANNOUNCES PRODUCT APPROVAL IN MEXICO | Press release | PR Newswire | +0.32% | +0.32% | |
| TABUK LAUNCHES VIBATIV® FDA-APPROVED ANTIBIOTIC WITH LIFE-SAVING POTENTIAL IN SAUDI ARABIA | Press release | PR Newswire | +0.65% | +2.27% | |
| Form 10-Q CUMBERLAND PHARMACEUTICA For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | -2.25% | -8.68% | |
| Cumberland Pharmaceuticals Reports 23% Revenue Growth Year-to-Date | Press release | PR Newswire | +10.17% | +8.81% | |
| Form 8-K CUMBERLAND PHARMACEUTICA For: Aug 05 | SEC filing · Form 8-K | SEC EDGAR | +10.17% | +8.81% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the CPIX section they belong to.
Where else CPIX is measured.
CPIX earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Intra-Cellular Therapies Inc. (ITCI) | 247 | -0.04% | 44% |
| Avadel Pharmaceuticals plc - Ordinary Share (AVDL) | 246 | -0.16% | 42% |
| electroCore, Inc. (ECOR) | 245 | 0.00% | 47% |
| Oragenics Inc. (OGEN) | 245 | -0.79% | 33% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Cumberland Pharmaceuticals Inc.'s median reaction calculated?
Every labeled CPIX news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 245 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 49% of CPIX's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does CPIX's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.